Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

TNFRSF10B anticorps (C-Term)

TNFRSF10B Reactivité: Humain WB, FACS, IHC, FM Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN6655116
  • Antigène Voir toutes TNFRSF10B Anticorps
    TNFRSF10B (Tumor Necrosis Factor Receptor Superfamily, Member 10b (TNFRSF10B))
    Épitope
    • 15
    • 7
    • 6
    • 4
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    C-Term
    Reactivité
    • 99
    • 20
    • 4
    • 1
    • 1
    Humain
    Hôte
    • 63
    • 40
    • 3
    • 2
    • 1
    • 1
    • 1
    Lapin
    Clonalité
    • 60
    • 48
    • 2
    Polyclonal
    Conjugué
    • 72
    • 11
    • 6
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp TNFRSF10B est non-conjugé
    Application
    • 74
    • 36
    • 31
    • 25
    • 17
    • 16
    • 15
    • 13
    • 12
    • 12
    • 8
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Flow Cytometry (FACS), Immunohistochemistry (IHC), Fluorescence Microscopy (FM)
    Purification
    Anti-DR5 Antibody was purified by Protein G chromatography. A BLAST analysis was used to suggest cross-reactivity with DR5 TRAILR2 from Human based on 100% homology with the immunizing sequence. Cross-reactivity with Anti-DR5 TRAILR2 from other sources has not been determined.
    Immunogène

    Immunogen: DR5 Antibody was produced from whole rabbit serum prepared by repeated immunizations with a peptide corresponding to amino acids near the c-terminus of human DR5.

    Immunogen Type: Peptide

    Isotype
    IgG
    Top Product
    Discover our top product TNFRSF10B Anticorps primaire
  • Indications d'application

    Immunohistochemistry Dilution: User Optimized

    Application Note: Anti-DR5 Antibody is suitable for use in Flow (Cell Surface) Cytometry, IF/ICC, IHC (paraffin), and WB. Expect a band approximately 47.9 kDa on specific lysates. Specific conditions for reactivity should be optimized by the end user.

    Flow Cytometry Dilution: User Optimized

    Western Blot Dilution: 5 μg/mL

    IF Microscopy Dilution: User Optimized

    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer

    Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2

    Stabilizer: 0.05 % BSA

    0.05 % (w/v) Sodium Azide
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    RT,4 °C,-20 °C
    Stockage commentaire
    Store DR5 antibody at -20° C prior to opening. Aliquot contents and freeze at -20° C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use.
  • Antigène
    TNFRSF10B (Tumor Necrosis Factor Receptor Superfamily, Member 10b (TNFRSF10B))
    Autre désignation
    DR5 (TNFRSF10B Produits)
    Synonymes
    anticorps TNFRSF10B, anticorps dr5, anticorps cd262, anticorps killer, anticorps trick2, anticorps trickb, anticorps xDR-M1, anticorps xDR-M2, anticorps ztnfr9, anticorps trailr2, anticorps trick2a, anticorps trick2b, anticorps CD262, anticorps DR5, anticorps KILLER, anticorps KILLER/DR5, anticorps TRAIL-R2, anticorps TRAILR2, anticorps TRICK2, anticorps TRICK2A, anticorps TRICK2B, anticorps TRICKB, anticorps ZTNFR9, anticorps Ly98, anticorps MK, anticorps tumor necrosis factor receptor superfamily, member 10b, anticorps tumor necrosis factor receptor superfamily member 10b S homeolog, anticorps tumor necrosis factor receptor superfamily member 10b L homeolog, anticorps tumor necrosis factor receptor superfamily member 10b, anticorps TNF receptor superfamily member 10b, anticorps Tnfrsf10b, anticorps TNFRSF10B, anticorps tnfrsf10b.S, anticorps tnfrsf10b.L, anticorps tnfrsf10b
    Sujet

    Synonyms: Tumor necrosis factor receptor superfamily member 10B, TNFRSF10B, DR5, KILLER, TRAILR2, TRICK2, ZTNFR9, Death receptor 5, TNF-related apoptosis-inducing ligand receptor 2, TRAIL receptor 2, TRAIL-R2, CD_antigen=CD262

    Background: DR5 TRAILR2 antibody detects human DR5 TrailR2. Apoptosis induced by certain cytokines including TNF and Fas ligand in the TNF family through their death domain containing receptors. TRAIL/Apo2L is a new member of the TNF family. DR4 was recently identified as the receptor for TRAIL. A novel death domain containing receptor for TRAIL was more recently identified and designated DR5, Apo2, TRAIL-R2, TRICK2, or KILLER by several groups independently. Like DR4, DR5 transcript is widely expressed in normal tissues and in many types of tumor cells. DR5 binds to TRAIL and mediates TRAIL induced cell death. Overexpression of DR5 induces apoptosis and activates NF-kB. Anti DR5 TRAILR2 is ideal for investigators involved in apoptosis and NF-kappa B research.

    Gene Name: TNFRSF10B

    ID gène
    8795
    NCBI Accession
    NP_003833
    UniProt
    O14763
    Pathways
    Signalisation p53, Apoptose, Positive Regulation of Endopeptidase Activity
Vous êtes ici:
Support technique